Zepbound vs Compounded Tirzepatide for Weight Loss: Results, Dosage & Side Effects

Key Takeaways

• Both Zepbound and compounded tirzepatide use the same active ingredient, tirzepatide (GLP-1/GIP), and follow the same once-weekly dosing schedule ranging from 2.5 mg up to 15 mg, with gradual increases to improve tolerance.
• Clinical trial data for Zepbound show average weight loss of up to 20.9% over 72 weeks at the 15 mg dose, and compounded tirzepatide may produce comparable results since it follows the same dosing and mechanism, though individual outcomes vary.
• Side effects are largely the same for both options, most commonly nausea, diarrhea, vomiting, constipation, and reduced appetite, with symptoms typically strongest during early treatment or after dose increases.
• The main differences are regulation and customization; Zepbound is fully FDA-approved and comes in prefilled pens, while compounded tirzepatide is prepared by licensed pharmacies, may include supportive additives, and has not been individually reviewed by the FDA.
• OrderlyMeds provides both brand-name Zepbound and compounded tirzepatide through a telehealth model with personalized dosing, ongoing provider access, and direct-to-home delivery.

Zepbound vs Compounded Tirzepatide for Weight Loss: An Overview

If you’ve been exploring GLP-1/GIP medications for weight loss, you’ve likely come across both Zepbound and compounded tirzepatide. Both contain the same active ingredient: tirzepatide, a dual GLP-1 and GIP receptor agonist, but they differ in how they’re manufactured, regulated, and priced.

Zepbound is the branded product made by Eli Lilly, carrying full FDA approval for chronic weight management. Compounded tirzepatide, on the other hand, is prepared by state-licensed compounding pharmacies and may include supportive additives tailored to individual patient needs. 

This article breaks down the results, dosage protocols, side effects, and cost differences so you can have a more informed conversation with your healthcare provider.

What Is Zepbound?

Zepbound is an FDA-approved prescription injection containing tirzepatide, indicated for chronic weight management in adults with a BMI of 30 or greater, or 27 or greater with at least one weight-related condition. It is also approved for moderate-to-severe obstructive sleep apnea in adults with obesity. 

Zepbound works by activating both GLP-1 and GIP hormone receptors, which help reduce appetite, slow gastric emptying, and promote a feeling of fullness after eating. It comes as a prefilled single-dose pen or single-dose vial and is self-administered once weekly as a subcutaneous injection.

What Is Compounded Tirzepatide?

Compounded tirzepatide uses the same active ingredient as Zepbound but is prepared by a licensed compounding pharmacy rather than the brand-name manufacturer. 

Compounded medications are indicated for patients when a prescribing practitioner determines that the compounded preparation produces a significant difference compared to the FDA-approved product, for example, through customized dosing, route of administration, or the inclusion of supportive additives like Vitamin B6 or B12.

Note that compounded tirzepatide has not been reviewed by the FDA for safety, efficacy, or quality. Patients should always consult a licensed provider to determine whether a compounded preparation is appropriate for their situation.

Dosage & Administration

Both Zepbound and compounded tirzepatide follow the same general dosing approach. The recommended starting dose is 2.5 mg injected subcutaneously once weekly. After four weeks, the dose increases to 5 mg weekly. From there, the dose can be increased by 2.5 mg, with a minimum of 4 weeks between adjustments, up to a maximum of 15 mg per week. The 2.5 mg dose is for treatment initiation only and is not a maintenance dose; recommended maintenance doses are 5 mg (for weight management), 10 mg, or 15 mg.

Injections can be administered in the abdomen, thigh, or upper arm, and injection sites should be rotated with each dose. Both forms are taken once weekly on the same day, at any time, with or without food. If a dose is missed, it should be taken as soon as possible within four days; if more than four days have passed, the missed dose should be skipped.

Through OrderlyMeds, new patients on compounded tirzepatide start with the 3-month SimpleStart program, which includes 12 total weekly doses: 4 doses of 2.5 mg, 4 doses of 5 mg, and 4 doses of 7.5 mg, so the body can gradually adjust.

Weight Loss Results

In the SURMOUNT-1 clinical trial, participants on the highest Zepbound dose (15 mg) achieved an average weight loss of 20.9% of their body weight (approximately 48 lbs) over 72 weeks when combined with a reduced-calorie diet and increased physical activity. Those on the 10 mg dose lost an average of 19.5% (approximately 44 lbs), and the 5 mg group lost about 15% (approximately 34 lbs), compared to 3.1% in the placebo group.

Because compounded tirzepatide contains the same active ingredient and follows the same dosing protocol, patients may achieve comparable weight-loss outcomes, though individual results vary based on factors such as starting weight, adherence, lifestyle habits, and overall health. Compounded medications do not have their own clinical trial data because they are not studied separately by the FDA.

Most patients may begin noticing some weight changes within the first four to eight weeks, with more significant results typically appearing within three to six months as the dose reaches therapeutic levels. As with any GLP-1/GIP medication, results are most meaningful when combined with balanced nutrition and regular movement.

Side Effects to Expect

The side-effect profiles of Zepbound and compounded tirzepatide are similar, as both deliver tirzepatide. The most commonly reported side effects include nausea, diarrhea, vomiting, constipation, abdominal pain, and decreased appetite. Many patients find that these gastrointestinal effects are most noticeable during the early weeks of treatment or following dose increases, and they tend to lessen as the body adjusts.

Less common but more serious potential side effects include pancreatitis, gallbladder problems, kidney issues, and severe allergic reactions. Zepbound also carries a boxed warning regarding thyroid C-cell tumors observed in animal studies, though it is not known if this risk applies to humans. Patients with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 should not use tirzepatide in any form.

Gradual dose escalation, starting at 2.5 mg and increasing slowly, is the primary strategy for minimizing side effects. Eating smaller meals, staying hydrated, and avoiding high-fat or fried foods may also help. If side effects persist or become severe, patients should contact their healthcare provider.

Zepbound vs Compounded Tirzepatide: Comparison Table

Feature	Compounded Tirzepatide (OrderlyMeds)	Zepbound (OrderlyMeds)
Active Ingredient	Tirzepatide	Tirzepatide
Mechanism	Dual GLP-1/GIP receptor agonist	Dual GLP-1/GIP receptor agonist
FDA Approved	No (compounded preparation)	Yes
Dosage Range	2.5 mg – 15 mg weekly	2.5 mg – 15 mg weekly
Administration	Subcutaneous injection (syringe)	Subcutaneous injection (pen)
Personalized Additives	May include B6, B12, or other supportive supplements	No
Common Side Effects	Nausea, diarrhea, vomiting, constipation	Nausea, diarrhea, vomiting, constipation
Expected Weight Loss	Comparable to Zepbound (same active ingredient)	Up to 20.9% body weight at 15 mg over 72 weeks
Provider Support	Ongoing telehealth access included	Ongoing telehealth access included
Delivery	Direct to home	Direct to home

How OrderlyMeds Supports Your Tirzepatide Weight Loss Journey

OrderlyMeds was built on the idea that medically supervised weight-loss care should be accessible, supportive, and sustainable. Our compounded tirzepatide program pairs every prescription with unlimited provider access, personalized dosing adjustments, and a holistic support system, including nutrition resources, expert-led webinars, and a community of real patients who understand the journey.

We take a telehealth-first approach, meaning patients in all 50 states can get started from home with an online health screening and provider consultation. As your body responds and your needs change, our medical team adjusts your care to keep pace. We also offer an optional mental health support partnership through BetterHelp, because we recognize that lasting progress involves more than medication alone.

With a 4.9-star Google rating and over 100,000 patients served, OrderlyMeds is committed to long-term, sustainable outcomes. Progress looks different for everyone, and our team is here to support every step of that process.

Check Your Eligibility & Get Started With OrderlyMeds 

Frequently Asked Questions (FAQs)

Is compounded tirzepatide the same as Zepbound?

Both contain tirzepatide as the active ingredient, but Zepbound is the FDA-approved branded product from Eli Lilly. Compounded tirzepatide is prepared by a licensed compounding pharmacy and has not been reviewed by the FDA for safety, efficacy, or quality.

What is the typical starting dose for tirzepatide?

The standard starting dose for both Zepbound and compounded tirzepatide is 2.5 mg injected subcutaneously once per week. This dose is gradually increased every 4 weeks based on the patient’s tolerance to the medication.

How long does it take to see weight-loss results with tirzepatide?

Most patients begin noticing changes within four to eight weeks. More significant weight loss typically occurs within 3 to 6 months as the dose is increased to therapeutic maintenance levels. Individual timelines vary.

Can I switch from Zepbound to compounded tirzepatide?

Many patients switch to compounded tirzepatide for cost reasons. A licensed provider can evaluate your current dose and history to ensure a smooth transition. OrderlyMeds accepts transfer patients who provide valid proof of their existing prescription.

Does OrderlyMeds offer both Zepbound and compounded tirzepatide?

Yes. OrderlyMeds provides both brand-name Zepbound and compounded tirzepatide through a single telehealth platform. Each option includes a provider consultation, personalized dosing, direct-to-home delivery, and ongoing medical support so patients can choose the form of tirzepatide that best fits their needs.

*Disclaimer: This article is for informational purposes only and does not constitute medical advice. OrderlyMeds provides compounded medications that have not been reviewed by the FDA for safety, efficacy, or quality. Always consult a licensed healthcare provider before starting any medication. Individual results vary, and medication should be used alongside healthy lifestyle practices.